Which is better, LLY or ONC?

On the Buffett-Fit framework, Eli Lilly and Company (LLY) currently grades higher than ONC — 72/100 (B grade) vs 62/100 (D). That said, "better" depends on which framework you trust — LLY wins on Warren Buffett, Benjamin Graham, Philip Fisher, Joel Greenblatt, Charlie Munger, and Terry Smith; ONC wins on Peter Lynch. The full pillar breakdown is on this page.

Should I buy LLY or ONC?

This page is an educational comparison, not investment advice. Both LLY and ONC are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is LLY better than ONC for value investing?

On the Buffett-style value-investing framework, LLY currently grades higher — 72/100 vs 62/100, a 10-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between LLY and ONC on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). LLY currently scores 72/100 (B grade); ONC scores 62/100 (D grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, LLY or ONC?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. LLY and ONC are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, LLY or ONC?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are LLY and ONC both Healthcare stocks?

Yes — both Eli Lilly and Company (LLY) and BeOne Medicines Ltd. (ONC) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this LLY vs ONC comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Eli Lilly

BeOne Medicines

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

LLY

Eli Lilly

Market cap

$1T

Sector

Healthcare

ONC

BeOne Medicines

Market cap

$33.15B

Sector

Healthcare

Overall winner

Eli Lilly LLY

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	LLY	ONC	Winner
Warren Buffett	72B	62D	LLY
Benjamin Graham	86A	75D	LLY
Philip Fisher	86A	84C	LLY
Peter Lynch	74B	75B	ONC
Joel Greenblatt	78C	49D	LLY
Charlie Munger	85A	56D	LLY
Terry Smith	77C	60D	LLY

Side-by-side metrics

Metric	LLY	ONC
Market cap	$1T	$33.15B
P/E (TTM)	36.6x	107.5x
EV/EBIT	34.1x	28.9x
ROIC (TTM)	32.06%	7.73%
Gross margin	83.51%	87.17%
Net margin	34.98%	8.93%
Revenue CAGR 5y	23.17%	45.99%
EPS CAGR 5y	40.81%	67.36%
Debt / Equity	1.4x	0.4x
Dividend yield	0.62%	0.0%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

LLY leads on

Dividend yield0.62%vs 0.0%+100%
Market cap$1Tvs $33.15B+97%
ROIC (TTM)32.06%vs 7.73%+76%
Net margin34.98%vs 8.93%+74%

ONC leads on

Debt / Equity0.4xvs 1.4x+69%
Revenue CAGR 5y45.99%vs 23.17%+50%
EPS CAGR 5y67.36%vs 40.81%+39%
EV/EBIT28.9xvs 34.1x+15%

More like LLY

LLY vs HALO LLY vs LMAT LLY vs RMD LLY vs UTHR LLY vs HAE LLY vs IDXX

More like ONC

ONC vs HALO ONC vs LMAT ONC vs RMD ONC vs UTHR ONC vs HAE ONC vs IDXX

Read the full Buffett-Brain analysis for LLY Read the full Buffett-Brain analysis for ONC

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Stock comparison

Eli Lilly

BeOne Medicines

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

LLY

Eli Lilly

Market cap

$1T

Sector

Healthcare

ONC

BeOne Medicines

Market cap

$33.15B

Sector

Healthcare

Overall winner

Eli Lilly LLY

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	LLY	ONC	Winner
Warren Buffett	72B	62D	LLY
Benjamin Graham	86A	75D	LLY
Philip Fisher	86A	84C	LLY
Peter Lynch	74B	75B	ONC
Joel Greenblatt	78C	49D	LLY
Charlie Munger	85A	56D	LLY
Terry Smith	77C	60D	LLY

Side-by-side metrics

Metric	LLY	ONC
Market cap	$1T	$33.15B
P/E (TTM)	36.6x	107.5x
EV/EBIT	34.1x	28.9x
ROIC (TTM)	32.06%	7.73%
Gross margin	83.51%	87.17%
Net margin	34.98%	8.93%
Revenue CAGR 5y	23.17%	45.99%
EPS CAGR 5y	40.81%	67.36%
Debt / Equity	1.4x	0.4x
Dividend yield	0.62%	0.0%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

LLY leads on

Dividend yield0.62%vs 0.0%+100%
Market cap$1Tvs $33.15B+97%
ROIC (TTM)32.06%vs 7.73%+76%
Net margin34.98%vs 8.93%+74%

ONC leads on

Debt / Equity0.4xvs 1.4x+69%
Revenue CAGR 5y45.99%vs 23.17%+50%
EPS CAGR 5y67.36%vs 40.81%+39%
EV/EBIT28.9xvs 34.1x+15%

More like LLY

LLY vs HALO LLY vs LMAT LLY vs RMD LLY vs UTHR LLY vs HAE LLY vs IDXX

More like ONC

ONC vs HALO ONC vs LMAT ONC vs RMD ONC vs UTHR ONC vs HAE ONC vs IDXX

Read the full Buffett-Brain analysis for LLY Read the full Buffett-Brain analysis for ONC

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.